跳至主要内容
临床试验/NCT05045079
NCT05045079已完成不适用

Tricuspid Regurgitation Due to Atrial Fibrillation - Impact of Rhythm Control and Early Surgery (TR-ES Study)

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2022年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
4
试验地点
2
主要终点
Change in KCCQ QOL scores

研究概览

简要总结

The purpose of this study is to understand the clinical impact of non-surgical and surgical treatment in atrial fibrillation induced tricuspid regurgitation (AFTR).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years.
  • Moderate-severe or severe TR while in atrial fibrillation.
  • Ambulatory (not wheelchair/scooter dependent).

排除标准

  • Systolic pulmonary artery pressure>70 mmHg with a fixed pulmonary vascular resistance >7 Wood units by catheterization.
  • Ejection fraction <40%.
  • Obstructive hypertrophic cardiomyopathy.
  • Constrictive pericarditis or tamponade.
  • Active myocarditis.
  • Complex congenital heart disease.
  • Other valve disease requiring surgical intervention.
  • Terminal illness (other than HF) with expected survival of less than 1 year.
  • Pregnancy or breastfeeding mothers.

结局指标

主要结局

Change in KCCQ QOL scores

时间窗: Baseline, 6 months

The KC Cardiomyopathy Questionnaire (0-100 scale) assess subject perception of heart failure limitation on their life; scale of extremely limited, quite a bit limited, moderately limited, slightly limited, not at all limited, limited for other reasons or did not do the activity.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yogesh Reddy

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验